New Line Medicines Private Limited - Company Profile

It is a chemicals private limited company based in Chilakaluripet, Andhra Pradesh, India, established in 2016.
2016 Chilakaluripet, Andhra Pradesh, India Active
Last Updated:
Access Report
About New Line Medicines Private Limited

New Line Medicines Private Limited, a active private limited company, was established on 19 March 2016 in Chilakaluripet, Andhra Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100AP2016PTC098568. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹3.10 M.

It upholds a compliant status. Its leadership includes Komala Devi Vankayalapati (Director), Srinivasa Rao Vankayalapati (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Door No : 1-1089 N T R Colony, Chilakaluripet, Andhra Pradesh, 522616.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100AP2016PTC098568

  • Registration Number

    098568

  • Incorporation Date

    19 March 2016

  • Authorized Capital

    ₹6.00 M

  • Paid-Up Capital

    ₹3.10 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 M
  • Paid Up Capital ₹ 3.10 M
  • Company Age 10 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
Company report

New Line Medicines Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into New Line Medicines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at New Line Medicines Private Limited?
Current Directors
Name Designation Appointment Date Status
Komala Devi Vankayalapati Director 19 Mar 2016 Current
Srinivasa Rao Vankayalapati Director 19 Mar 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of New Line Medicines.

New Line Medicines Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

New Line Medicines revenue growth over time
New Line Medicines profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of New Line Medicines?

Unlock access to New Line Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at New Line Medicines?

Unlock and access historical data on people associated with New Line Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of New Line Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Line Medicines's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on New Line Medicines
Recent Activity within the Organization
  • Annual General Meeting

    New Line Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on New Line Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was documented.

  • Director Appointment

    The activity Komala Devi Vankayalapati was appointed as a Director was appointed as a Director on 19 Mar 2016 & has been associated with this company since 10 years 2 months . was completed.

  • Director Appointment

    Srinivasa Rao Vankayalapati was appointed as a Director was appointed as a Director on 19 Mar 2016 & has been associated with this company since 10 years 2 months . was recorded as a recent event.

  • Company Incorporation

    New Line Medicines Private Limited was registered on 19 Mar 2016 with Roc Vijayawada & aged 10 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of New Line Medicines Private Limited?

The CIN of New Line Medicines Private Limited is U24100AP2016PTC098568.

Where is New Line Medicines Private Limited headquartered?

New Line Medicines Private Limited is headquartered at Door No : 1-1089 N T R Colony, Chilakaluripet, Andhra Pradesh, 522616.

When was New Line Medicines Private Limited incorporated?

New Line Medicines Private Limited was incorporated on 19 March 2016.

Who are the current directors of New Line Medicines Private Limited?

The current directors of New Line Medicines Private Limited are

What is the primary industry of New Line Medicines Private Limited?

The primary industry of New Line Medicines Private Limited is Chemicals.

Is New Line Medicines Private Limited a listed company?

New Line Medicines Private Limited is unlisted.

What is the capital structure of New Line Medicines Private Limited?

The authorized capital of New Line Medicines Private Limited is ₹6.00 M, and the paid-up capital is ₹3.10 M.

What is the compliance status of New Line Medicines Private Limited?

The compliance status of New Line Medicines Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available